These three innovators to know are responsible for solving problems here in Houston. Courtesy photos

A good innovator sees a need and fills it. Whether it's a bigger budget for new hospital technology, a network for female software developers in Houston, or access to creatives for nonprofits, these three Houston innovators are responsible for filling the needs of Houston's innovation ecosystem.

Roberta Schwartz, chief innovation officer of Houston Methodist

Roberta Schwartz is leading the innovation initiative at Houston Methodist. Courtesy of Houston Methodist

Houston Methodist has always been an innovative hospital system, says Roberta Schwartz, chief innovation officer, so it was not really that surprising that a group of hospital officials had an interest in new technologies.

"As we watched these technologies come in, we found that there were a number of us within the organization that were just talking about it all the time and watching how we could really revolutionize the way we worked by embracing these new technologies," Schwartz says.

The group named itself the "digital innovation obsessed people," however, now that group calls itself the Houston Methodist Center for Innovation, and Schwartz is leading the initiative. Read more about Schwartz and the new center here. 

Alex Anderson, founder of Good Measure

Alex Anderson started Good Measure to help nonprofits have access to creatives and storytelling tools. Courtesy of Alex Anderson

Houston-based nonprofit, Good Measure, completed its third creative workshop last week — and its first outside of Houston. Nuu Group's Alex Anderson and Tres Garner founded Good Measure to help nonprofits with storytelling and media, and they took their efforts to New York City to work with Memphis-based youth violence nonprofit, Grounded.

Just like the last Good Measure project, volunteer creatives has less than 72 hours to create a slew of branding materials, including user experience-focused designs, web pages, photos, videos, and more for the nonprofit.

"My hope is that each and every individual who attended sees the impact that our craft skills can make," Anderson wrote in a post on Medium. "We certainly can volunteer our time and work with nonprofits, but the real question is whether we can return to our day jobs, to clients with big budgets and capitalistic mindsets, and influence their decisions—to push them from opportunistic to purposeful."

Silver Ehiwario, director of Women Who Code Houston Chapter

Silver Ehiwario flipped careers a while back, and now she hopes to help other women with that process. Courtesy of Silver Ehiwario

Making a career switch is never easy — but it's extremely hard for women trying to enter the technology industry. Women Who Code, a global organization, just opened up shop in Houston, thanks to seven female directors, including Silver Ehiwario, who changed her career to tech recently.

"We are able to see a lot of people are changing their careers from what they have done before — just like I changed mine," she says. "We need communities where they can be inspired." Read more about Ehiwario and Women Who Code here.

Silver Ehiwario flipped careers a while back, and now she hopes to help other women with that process. Courtesy of Silver Ehiwario

Houston software developer helps bring Women Who Code to town

Featured Innovator

Silver Ehiwario worked to attain two chemical engineering degrees and had been in the industry in Nigeria for seven years when she decided she wanted to change her career path.

"I started thinking about making a switch when I found out I had this interest in being creative and building solutions for businesses so that they can become more effective and grow," Ehiwario says. "I like to be able to put my thoughts into the computer and see people use it."

She's not alone. Ehiwario and a few like-minded women are responsible for bringing the California-based nonprofit organization, Women Who Code, to Houston. On March 5, the Houston chapter celebrated its launch. At the event, the organization engaged its new members and asked them what they wanted from the organization. The feedback they received will drive the programing and events they will focus on, Ehiwario says.

"At the end of the day, I called for anyone open to mentoring. We had a whole lot of turnout — people were ready to inspire other women with what they do best," Ehiwario says. "I don't think there is a whole lot of other groups out there where your interest is represented and worked on."

Ehiwario spoke with InnovationMap about what she's excited about for Women Who Code in Houston and how she managed to change careers from a chemical engineer to a software developer.

InnovationMap: Did you find it easy to find resources for starting a new career in coding?

Silver Ehiwario: It wasn't easy — maybe I didn't know what I wanted. I searched online for something I could actually do where I wanted to do it. I decided to try the University of Texas' bootcamp here in Houston. It was very hard at first. I was very new to coding. I never used the computer other than for emails and basic work.

IM: How did you first get involved with Women Who Code?

SE: I had a colleague in the bootcamp who introduced me to it. I found out more online and it kind of aligned with what I wanted and I liked the idea of having support. In 2017, I applied to be a director so that we could have a network here. Everything started happening here at the end of 2018.

IM: Who is a part of the Houston chapter?

SE: There are seven of us. Julie Jonak, Roopa Rajala, Shefali Kapoor-Patel, Wanjun Zhang, Aditi Singh, Saima Rajwani, and myself.

IM: What's the program like?

SE: What draws me to Women Who Code is the mission and the vision. The mission is to inspire women to excel in their technology careers, and the vision is to have a world where women are representative of technical executives, founders, chairmen, and software engineer. We have people old and young. Our code of conduct has to do with inclusiveness — if you love technology, you're welcomed.

IM: Why is it important to Houston that Women Who Code have a chapter here?

SE: Houston is a huge community. I know there's a lot of tech people out here. We are able to see a lot of people are changing their careers from what they have done before — just like I changed mine. We need communities where they can be inspired. I've met people who just finished a coding bootcamp, are job hunting, and are kind of depressed. This community will be able to inspire them.

We need Women Who Code in Houston to support these women in tech — to close the gender gap and create a good working environment. If women succeed, girls will see that and it will give them that encouragement and motivation.

IM: How does someone get involved?

SE: Online. Sign up to be a member, join our Facebook network, and our LinkedIn network. We'll soon roll out our schedule of when we meet.

IM: Advice for someone wanting to switch careers?

SE: I like talking about this a lot. If you want to change your career to something in the tech industry, I would just say to take it one step at a time. Find one of the bootcamps out there and get connected. And join a network like Women Who Code so you can have a network and support after you leave that bootcamp.

------

Portions of this interview have been edited.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.